AGER and kidney disorder: In previous studies, the AGEs-RAGE pathway is widely recognized as a pro-inflammatory mechanism in nephropathy, and the therapeutic blockade of RAGE ameliorated renal and endothelial functions under a high AGEs burden (Yeh et al. 2017).